Giant Biogene Holding Co., Ltd. (HKG:2367)

Giant Biogene Holding Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	5,539	3,524	2,364	1,552	1,190
Revenue Growth (YoY)	57.17%	49.05%	52.30%	30.41%	24.44%
Cost of Revenue	991.9	577.01	369.21	198.15	183.41
Gross Profit	4,547	2,947	1,995	1,354	1,007
Selling, General & Admin	2,159	1,261	817.44	418.49	189.41
Research & Development	106.5	74.97	44.04	24.95	13.38
Other Operating Expenses	-	-	-	-	2
Operating Expenses	2,265	1,335	862.1	443.77	202.32
Operating Income	2,282	1,612	1,133	910.57	804.75
Interest Expense	-0.24	-0.11	-0.02	-	-
Interest & Investment Income	111.35	47.49	13.16	9.41	9.88
Earnings From Equity Investments	-3.6	-	-	-	-
Currency Exchange Gain (Loss)	-3.59	1.09	-14.45	21.61	-
Other Non Operating Income (Expenses)	28.36	55.58	54.2	16.86	3.83
EBT Excluding Unusual Items	2,414	1,716	1,186	958.44	818.46
Gain (Loss) on Sale of Investments	43.27	29.33	-8.28	14.47	154.78
Gain (Loss) on Sale of Assets	0.67	-	-	-	-
Pretax Income	2,458	1,745	1,178	972.92	973.24
Income Tax Expense	396.03	296.89	176.16	144.79	146.76
Earnings From Continuing Operations	2,062	1,448	1,002	828.13	826.49
Minority Interest in Earnings	0.62	3.55	0.44	-	-0.04
Net Income	2,062	1,452	1,002	828.13	826.45
Preferred Dividends & Other Adjustments	-	-	306.03	19.32	-
Net Income to Common	2,062	1,452	696	808.81	826.45
Net Income Growth	42.06%	44.88%	21.00%	0.20%	49.65%
Shares Outstanding (Basic)	982	976	703	975	1,000
Shares Outstanding (Diluted)	1,002	983	1,021	1,001	1,000
Shares Change (YoY)	1.93%	-3.77%	2.03%	0.09%	-
EPS (Basic)	2.10	1.49	0.99	0.83	0.83
EPS (Diluted)	2.06	1.48	0.98	0.83	0.83
EPS Growth	39.19%	50.83%	18.70%	0.03%	50.26%
Free Cash Flow	1,794	1,421	778.97	617.4	758.62
Free Cash Flow Per Share	1.79	1.45	0.76	0.62	0.76
Dividend Per Share	0.602	0.440	-	-	-
Dividend Growth	36.84%	-	-	-	-
Gross Margin	82.09%	83.63%	84.39%	87.24%	84.59%
Operating Margin	41.19%	45.73%	47.92%	58.65%	67.60%
Profit Margin	37.23%	41.19%	29.44%	52.10%	69.42%
Free Cash Flow Margin	32.40%	40.33%	32.95%	39.77%	63.72%
EBITDA	2,325	1,643	1,159	933.64	826.02
EBITDA Margin	41.98%	46.63%	49.00%	60.14%	69.39%
D&A For EBITDA	43.92	31.62	25.53	23.07	21.27
EBIT	2,282	1,612	1,133	910.57	804.75
EBIT Margin	41.19%	45.73%	47.92%	58.65%	67.60%
Effective Tax Rate	16.11%	17.01%	14.96%	14.88%	15.08%

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.